Marshall Wace North America’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Marshall Wace North America's ZBH Position: Q3 2021 in Review
Marshall Wace North America reduced its Zimmer Biomet (ZBH) stake by 66% in Q3 2021, selling an estimated $63.8M and leaving 222,908 shares worth $31.7M. The position accounts for 0.13% of the portfolio, ranked #173.
Marshall Wace North America first reported a position in ZBH in Q4 2013 and has held it in 17 quarters since. The position peaked at $157M in Q3 2020. 983 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.
- Marshall Wace North America held 222,908 shares of Zimmer Biomet worth $31.7M as of Q3 2021.
- Marshall Wace North America sold 433,584 Zimmer Biomet shares in Q3 2021, an estimated $63.8M.
- Zimmer Biomet made up 0.13% of Marshall Wace North America's portfolio in Q3 2021, its #173 holding.
- Marshall Wace North America first reported a position in Zimmer Biomet in Q4 2013 and has held it in 17 quarters since.
- Marshall Wace North America's Zimmer Biomet position peaked at $157M in Q3 2020.
- 983 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.